<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Macular <z:mpath ids='MPATH_127'>atrophy</z:mpath> or <z:e sem="disease" ids="C1288283" disease_type="Disease or Syndrome" abbrv="">anetoderma</z:e> is a rare <z:e sem="disease" ids="C0037274" disease_type="Disease or Syndrome" abbrv="">skin disease</z:e> of unknown pathogenesis, characterised by wrinkled or flaccid skin </plain></SENT>
<SENT sid="1" pm="."><plain>OBJECTIVE: The finding of <z:e sem="disease" ids="C1288283" disease_type="Disease or Syndrome" abbrv="">anetoderma</z:e> in 5 patients followed up because of false-positive seroreactions of <z:e sem="disease" ids="C0039128" disease_type="Disease or Syndrome" abbrv="">syphilis</z:e> prompted us to study the occurrence of antiphospholipid (aPL) antibodies in <z:e sem="disease" ids="C1288283" disease_type="Disease or Syndrome" abbrv="">anetoderma</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: 14 unselected patients with <z:e sem="disease" ids="C0406550" disease_type="Disease or Syndrome" abbrv="">primary anetoderma</z:e> (PA) were collected from hospital records and clinical, immunological and histological findings were compared in the two patient groups </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Of the 5 patients, 3 fulfilled the criteria for <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>In two cases, it was secondary to <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) </plain></SENT>
<SENT sid="5" pm="."><plain>Of the 14 PA patients 1 had aPL antibodies and 4 had borrelia antibodies </plain></SENT>
<SENT sid="6" pm="."><plain>Two patients had thyroid antibodies; 1 of them developed SLE </plain></SENT>
<SENT sid="7" pm="."><plain>In several biopsy specimens, microthromboses were seen in both patient groups </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: On the basis of this study and our previous findings, it seems that <z:e sem="disease" ids="C1288283" disease_type="Disease or Syndrome" abbrv="">anetoderma</z:e> is more often associated with aPL-positive SLE or <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e>-like disease than with aPL-negative disease </plain></SENT>
<SENT sid="9" pm="."><plain>Immunological mechanisms play an important role in both primary and <z:e sem="disease" ids="C0406553" disease_type="Disease or Syndrome" abbrv="">secondary anetoderma</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>The meaning of false-positive serological tests for <z:e sem="disease" ids="C0039128" disease_type="Disease or Syndrome" abbrv="">syphilis</z:e> or borrelia and aPL antibodies is not clear, but they may be reacting to some still unidentified antigen </plain></SENT>
<SENT sid="11" pm="."><plain>Probably, various systemic as well as local inflammatory and non-inflammatory processes, e.g. microthromboses, can trigger <z:e sem="disease" ids="C1288283" disease_type="Disease or Syndrome" abbrv="">anetoderma</z:e> via still unknown pathomechanisms </plain></SENT>
</text></document>